Companies staffed by humans are divided into managers and employees, and it seems that AI organizations could be structured ...
JPMorgan upgraded Recursion Pharmaceuticals (RXRX) to Overweight from Neutral with a price target of $11, up from $10. The firm says the company’s REC-4881 has shown “strong and durable” efficacy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback